NO20021083L - Pyrazolo[4,3-d]pyrimidiner - Google Patents

Pyrazolo[4,3-d]pyrimidiner

Info

Publication number
NO20021083L
NO20021083L NO20021083A NO20021083A NO20021083L NO 20021083 L NO20021083 L NO 20021083L NO 20021083 A NO20021083 A NO 20021083A NO 20021083 A NO20021083 A NO 20021083A NO 20021083 L NO20021083 L NO 20021083L
Authority
NO
Norway
Prior art keywords
pyrazolo
pyrimidines
phosphodiesterase
inhibition
therapy
Prior art date
Application number
NO20021083A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021083D0 (no
Inventor
Rochus Jonas
Hans-Michael Eggenweiler
Pierre Schelling
Maria Christadler
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20021083D0 publication Critical patent/NO20021083D0/no
Publication of NO20021083L publication Critical patent/NO20021083L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20021083A 1999-09-06 2002-03-05 Pyrazolo[4,3-d]pyrimidiner NO20021083L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19942474A DE19942474A1 (de) 1999-09-06 1999-09-06 Pyrazolo[4,3-d]pyrimidine
PCT/EP2000/008257 WO2001018004A2 (de) 1999-09-06 2000-08-24 PYRAZOLO[4,3-d]PYRIMIDINE

Publications (2)

Publication Number Publication Date
NO20021083D0 NO20021083D0 (no) 2002-03-05
NO20021083L true NO20021083L (no) 2002-03-05

Family

ID=7920966

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021083A NO20021083L (no) 1999-09-06 2002-03-05 Pyrazolo[4,3-d]pyrimidiner

Country Status (23)

Country Link
US (1) US6777419B1 (hu)
EP (1) EP1210349B1 (hu)
JP (1) JP4975921B2 (hu)
KR (1) KR20020025253A (hu)
CN (1) CN1145627C (hu)
AR (1) AR025569A1 (hu)
AT (1) ATE231866T1 (hu)
AU (1) AU773878B2 (hu)
BR (1) BR0013781A (hu)
CA (1) CA2384037C (hu)
CZ (1) CZ294587B6 (hu)
DE (2) DE19942474A1 (hu)
DK (1) DK1210349T3 (hu)
ES (1) ES2189766T3 (hu)
HU (1) HUP0202624A3 (hu)
MX (1) MXPA02002383A (hu)
NO (1) NO20021083L (hu)
PL (1) PL353366A1 (hu)
PT (1) PT1210349E (hu)
RU (1) RU2249594C2 (hu)
SK (1) SK3132002A3 (hu)
WO (1) WO2001018004A2 (hu)
ZA (1) ZA200202653B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10031584A1 (de) 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
WO2002049651A1 (de) * 2000-12-19 2002-06-27 Merck Patent Gmbh Pharmazeutische formulierung enthaltend pyrazolo[4,3-d]pyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate
DE10103647A1 (de) * 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
OA13050A (en) 2003-04-29 2006-11-10 Pfizer Ltd 5,7-diaminopyrazolo [4,3-D] pyrimidines useful in the treatment of hypertension.
US7572799B2 (en) * 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
GB0327323D0 (en) * 2003-11-24 2003-12-31 Pfizer Ltd Novel pharmaceuticals
EP1742950B1 (en) * 2004-04-07 2008-12-17 Pfizer Limited Pyrazolo[4,3-d] pyrimidines
NZ564187A (en) 2005-05-12 2010-03-26 Pfizer Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
NL2000291C2 (nl) 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
US9802937B2 (en) * 2011-04-21 2017-10-31 Origenis Gmbh Substituted pyrazolo{4,3-D}pyrimidines as kinase inhibitors
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
US10034861B2 (en) * 2016-07-04 2018-07-31 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
AR113926A1 (es) 2017-12-14 2020-07-01 H Lundbeck As Derivados de 1h-pirazolo[4,3-b]piridinas
SG11202005361RA (en) 2017-12-14 2020-07-29 H Lundbeck As Combination treatments comprising administration of 1h-pyrazolo[4,3-b]pyridines
US11535611B2 (en) 2017-12-20 2022-12-27 H. Lundbeck A/S Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors
US10766893B2 (en) * 2017-12-20 2020-09-08 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256650A (en) * 1989-03-29 1993-10-26 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
KR100390612B1 (ko) 1997-04-25 2003-07-07 화이자 인코포레이티드 타입 5 시클릭 구아노신 3',5'-모노포스페이트포스포디에스테라제를 억제하는 성기능 장애 치료용피라졸로피리미디논 제조용 중간체의 제조 방법
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE10031584A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
DE10060388A1 (de) * 2000-12-05 2002-06-06 Merck Patent Gmbh Verwendung von Pyrazolo [4,3-d]pyrimidinen
DE10103647A1 (de) * 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates

Also Published As

Publication number Publication date
AU773878B2 (en) 2004-06-10
MXPA02002383A (es) 2002-09-02
CA2384037A1 (en) 2001-03-15
NO20021083D0 (no) 2002-03-05
PT1210349E (pt) 2003-06-30
RU2249594C2 (ru) 2005-04-10
EP1210349B1 (de) 2003-01-29
KR20020025253A (ko) 2002-04-03
BR0013781A (pt) 2002-05-14
ES2189766T3 (es) 2003-07-16
ZA200202653B (en) 2003-09-23
DK1210349T3 (da) 2003-05-19
CZ2002736A3 (cs) 2002-05-15
HUP0202624A3 (en) 2004-11-29
CZ294587B6 (cs) 2005-02-16
CN1377357A (zh) 2002-10-30
CN1145627C (zh) 2004-04-14
AR025569A1 (es) 2002-12-04
PL353366A1 (en) 2003-11-17
AU7279300A (en) 2001-04-10
JP2003508534A (ja) 2003-03-04
DE50001191D1 (de) 2003-03-06
ATE231866T1 (de) 2003-02-15
SK3132002A3 (en) 2002-07-02
HUP0202624A2 (hu) 2002-12-28
CA2384037C (en) 2009-10-13
JP4975921B2 (ja) 2012-07-11
US6777419B1 (en) 2004-08-17
EP1210349A2 (de) 2002-06-05
WO2001018004A2 (de) 2001-03-15
DE19942474A1 (de) 2001-03-15
WO2001018004A3 (de) 2001-08-09

Similar Documents

Publication Publication Date Title
NO20021083L (no) Pyrazolo[4,3-d]pyrimidiner
NO20002702L (no) Tienopyrimidiner
NO991951L (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
GEP20043303B (en) Polycycloalkylpurines as Adenosine Receptor Antagonists
NO984081L (no) Pyrimido[5,4-d]pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremtilling derav
DE69410121D1 (en) Dihydro pyrazolopyrrole
GEP20084528B (en) 5,7-DIAMINOPYRAZOLO [4,3-d] PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY
NO20054208L (no) Nitrogen-substituerte heksahydropyrazino[1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
NO20056032L (no) Nye pyridopyraziner og anvendelse derav som kinasemodulatorer
BG101289A (en) Pyrimido/5,4-d/pyrimidines, medicamentous forms containing them, their application and method for their preparation
NO991761L (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
CA2367704A1 (en) Pyrazolobenzodiazepines as cdk2 inhibitors
NO20043851L (no) Derivater av 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidin med CDK inhibitorisk aktivitet
NO20021379L (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
NO20072046L (no) Halogensubstituerte benzodiazepinderivater
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
DK1107973T3 (da) Hidtil ukendte thieno(2,3-D)pyrimidindioner, fremgangsmåde til deres fremstilling og anvendelse deraf i terapi
TR200402342T4 (tr) 2-Pirindinil-6,7,8,9- Tetrahidropyrimido[1,2-A] Pirimidin-4-On ve 7-Pirindinil-1,3-Dihydoimidazo[1,2-A]Pirimidin-5(1H) on Türevleri
DE50211929D1 (en) Pyrimidinderivate
MY133785A (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
GEP20043267B (en) Adenosine Receptor Antagonists, Methods of Making and Using the Same
NO942095L (no) Imidazopyridiner
UA42731C2 (uk) Арилалкілтіадіазинони, спосіб їх отримання, фармацевтична композиція, спосіб її отримання, спосіб лікування
NO982863L (no) Nye forbindelser med analgetisk effekt

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application